1. Petrosky E, Bocchini JA Jr, Hariri S, Chesson H, Curtis CR, Saraiya et al (2015) Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 64:300–304
2. Insinga RP (2006) Annual productivity costs due to cervical cancer mortality in the United States. Womens Health Issues 16:236–242
3. Insinga RP, Dasbach EJ, Elbasha EH (2005) Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US. Pharmacoeconomics 23:1107–1122
4. Rimer BK, Harper H, Witte ON (2014) Accelerating HPV vaccine uptake: Urgency for action to prevent cancer. In: A report to the President of the United States from the President’s Cancer Panel. National Cancer Institute, Bethesda, MD
5. Centers for Disease Control and Prevention (2015) 2014 NIS-Teen vaccination coverage table data. Estimated vaccination coverage among adolescents aged 13–17 years by race/ethnicity for selected vaccines Available at:
http://www2a.cdc.gov/nip/coverage/nisteen/CountNIS-TEEN.asp?fmt=r&rpt=tab17_race_nat_2014.pdf&qtr=Q1/2014-Q4/2014
. Accessed Aug 2016